Dr Kabil has been the executive director of the National Committee for Prevention & Control of Viral Hepatitis since its establishment in 2006. He has managed all the administrative and logistic efforts of establishing specialized treatment centers for HCV, has overseen the purchase and supply chain of all medications necessary for treating more than 2 million patients to date, and has been pivotal in planning and managing the training efforts for all participating physicians in the now more than 150 treatment centers.